Skip to main navigation Skip to search Skip to main content

The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR study

  • Christian Rolfo
  • , David E. Gerber
  • , Rupesh Kotecha
  • , Jeffrey P. Ward
  • , Wallace Akerley
  • , Lukas Weiss
  • , Ariel Naveh
  • , Nadav Shapira
  • , Ticiana Leal
  • , Corey J. Langer

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number108802
JournalLung Cancer
Volume210
DOIs
StatePublished - Dec 2025

ASJC Scopus Subject Areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Keywords

  • Body mass index
  • Immune checkpoint inhibitor
  • Non-small cell lung cancer
  • PD-L1 inhibitor
  • TTFields therapy
  • Tumor Treating Fields

Cite this